Works matching DE "ELAN Corp. PLC"

Results: 43

Alzheimer's disease: Vaccine revisited.

Published in:

Nature Reviews Immunology, 2002, v. 2, n. 11, p. 811, doi. 10.1038/nri948

By:

Frantz, Simon

Publication type:

Article

The clinical profile of elan pharmaceuticals' botulinum toxin type B.

Published in:

European Journal of Neurology, 2001, v. 8, p. 13, doi. 10.1046/j.1468-1331.2001.00004.x

By:

O'Brien, C. F.

Publication type:

Article

First therapy targeting Parkinson's proteins enters clinical trials.

Published in:

Nature Medicine, 2012, v. 18, n. 7, p. 992, doi. 10.1038/nm0712-992b

By:

Dolgin, Elie

Publication type:

Article

Set back to Alzheimer vaccine studies.

Published in:

Nature Medicine, 2002, v. 8, n. 3, p. 199, doi. 10.1038/nm0302-199b

By:

Birmingham, Karen;
Frantz, Simon

Publication type:

Article

New drugs and dosage forms.

Published in:: American Journal of Health-System Pharmacy, 2004, v. 61, n. 11, p. 1092, doi. 10.1093/ajhp/61.11.1092
Publication type:: Article

Andrx v Elan: The Eleventh Circuit applies its Schering-Plough v FTC decision.

Published in:

Journal of Generic Medicines, 2006, v. 3, n. 2, p. 147, doi. 10.1057/palgrave.jgm.4940112

By:

Rein, Frederick H.;
Kessel, Amanda M.

Publication type:

Article

Tysabri drug rights battle to end.

Published in:

Chemistry & Industry, 2009, n. 18, p. 6

By:

Dorey, Emma

Publication type:

Article

Elan and Biogen square up for fight over Tysabri.

Published in:

Chemistry & Industry, 2009, n. 16, p. 5

By:

Emma Dorey

Publication type:

Article

Elan's ceo lashes out over drug prices.

Published in:

Chemistry & Industry, 2007, n. 11, p. 11

By:

Dorey, Emma

Publication type:

Article

Trials halted in wake of Tysabri withdrawal.

Published in:

Chemistry & Industry, 2005, n. 7, p. 7

By:

Dorey, Emma

Publication type:

Article

News in brief.

Published in:: Chemistry & Industry, 2005, n. 5, p. 4
Publication type:: Article

News.

Published in:: Chemistry & Industry, 2004, n. 23, p. 6
Publication type:: Article

Elan on road to recovery?

Published in:

Chemistry & Industry, 2004, n. 16, p. 10

By:

Dorey, Emma

Publication type:

Article

Wall Street broker to head Elan pharma.

Published in:: Chemistry & Industry, 2003, n. 2, p. 4
Publication type:: Article

STUDIES PRESENTED AT INTERNATIONAL CONFERENCE ON ALZHEIMER'S DISEASE REVEAL SUBSTANTIAL ECONOMIC COSTS AND CAREGIVER BURDEN ASSOCIATED WITH ALZHEIMER'S DISEASE.

Published in:: 2009
Publication type:: Proceeding

The comeback kid: TYSABRI now FDA approved for Crohn disease.

Published in:

2008

By:

Honey, Karen

Publication type:

journal article

Alzheimer's disease: Vaccine revisited.

Published in:

Nature Reviews Drug Discovery, 2002, v. 1, n. 12, p. 933, doi. 10.1038/nrd971

By:

Frantz, Simon

Publication type:

Article

J&J's billion dollar punt on anti-amyloid antibody.

Published in:

Nature Biotechnology, 2009, v. 27, n. 8, p. 679, doi. 10.1038/nbt0809-679

By:

Sheridan, Cormac

Publication type:

Article

Irish biotech buoyant.

Published in:

Nature Biotechnology, 2009, v. 27, n. 5, p. 408, doi. 10.1038/nbt0509-408a

By:

Sheridan, Cormac

Publication type:

Article

Tysabri's troubles return.

Published in:

Nature Biotechnology, 2008, v. 26, n. 10, p. 1061, doi. 10.1038/nbt1008-1061

By:

Hoag, Hannah

Publication type:

Article

Myriad stumbles, Wyeth closes on Alzheimer's.

Published in:

Nature Biotechnology, 2008, v. 26, n. 8, p. 841, doi. 10.1038/nbt0808-841

By:

Osborne, Randy

Publication type:

Article

Fast track to MS drug.

Published in:

Nature Biotechnology, 2004, v. 22, n. 8, p. 939, doi. 10.1038/nbt0804-939

By:

Sheridan, Cormac

Publication type:

Article

Is Elan a turnaround?

Published in:

Nature Biotechnology, 2003, v. 21, n. 9, p. 985, doi. 10.1038/nbt0903-985

By:

Jacobs, Tom

Publication type:

Article

RESEARCH NEWS.

Published in:: Nature Biotechnology, 2003, v. 21, n. 2, p. 141
Publication type:: Article

Elan's attack of Enronitis.

Published in:

Nature Biotechnology, 2002, v. 20, n. 5, p. 429, doi. 10.1038/nbt0502-429

By:

Jacobs, Tom

Publication type:

Article

In Brief.

Published in:

Nature Biotechnology, 2002, v. 20, n. 4, p. 327, doi. 10.1038/nbt0402-327

By:

L.F.;
A.B.;
J.F.

Publication type:

Article

Vaccine tests key Alzheimer's disease hypothesis.

Published in:

Nature Biotechnology, 2001, v. 19, n. 2, p. 104, doi. 10.1038/84340

By:

Fletcher, Liz

Publication type:

Article

Elan buys Liposome.

Published in:

Nature Biotechnology, 2000, v. 18, n. 4, p. 367, doi. 10.1038/74358

By:

Grisham, Julie

Publication type:

Article

Athersys all the RAGE.

Published in:

Nature Biotechnology, 2000, v. 18, n. 3, p. 245, doi. 10.1038/73602

By:

Dorey, Emma

Publication type:

Article

Morphine Oral - Elan Corporation: Avinza™.

Published in:: Drugs in R&D, 2002, v. 3, n. 3, p. 208, doi. 10.2165/00126839-200203030-00015
Publication type:: Article

FDA approves new non-narcotic for pain.

Published in:: American Journal of Hospice & Palliative Medicine, 2005, v. 22, n. 2, p. 87
Publication type:: Article

Elan, Enron, and the Aftermath of Scandal: A Comparative Analysis of Recent Irish and American Corporate Governance Legislation.

Published in:

California Western International Law Journal, 2008, v. 39, n. 1, p. 1

By:

GUPTA, MANISH

Publication type:

Article

Elan creates R&D spin-out.

Published in:: TCE: The Chemical Engineer, 2012, n. 855, p. 11
Publication type:: Article

Alzheimer's vaccine trials suspended.

Published in:: Brown University Psychopharmacology Update, 2002, v. 13, n. 3, p. 8
Publication type:: Article

An extended-release dosage form of the selective serotonin reuptake inhibitor (SSRI) fluvoxamine...

Published in:: Brown University Psychopharmacology Update, 1998, v. 9, n. 4, p. 5
Publication type:: Article

Call for Elan to publish Alzheimer's trial details.

Published in:

Nature, 2002, v. 416, n. 6882, p. 677, doi. 10.1038/416677d

By:

Bishop, Glenda M.;
Robinson, Stephen R.;
Smith, Mark A.;
Perry, George;
Atwood, Craig S.

Publication type:

Article

Patent suit on Alzheimer's mouse rejected...

Published in:

Nature, 2000, v. 405, n. 6790, p. 989, doi. 10.1038/35016722

By:

Dalton, Rex

Publication type:

Article

Researchers caught in dispute over transgenic mice patents.

Published in:

Nature, 2000, v. 404, n. 6776, p. 319, doi. 10.1038/35006215

By:

Dalton, Rex

Publication type:

Article

FDA asked to review Antegren.

Published in:: Inside MS, 2004, v. 22, n. 4, p. 27
Publication type:: Article

Elan's Irish tax allure.

Published in:

Nature Biotechnology, 2013, v. 31, n. 10, p. 864, doi. 10.1038/nbt1013-864

By:

Waltz, Emily

Publication type:

Article

Social networks attempt to spark academic-university collaborations.

Published in:

Nature Biotechnology, 2012, v. 30, n. 10, p. 901, doi. 10.1038/nbt1012-901

By:

Weintraub, Arlene

Publication type:

Article

Elan splits in two.

Published in:

Nature Biotechnology, 2012, v. 30, n. 10, p. 902, doi. 10.1038/nbt1012-902

By:

Proffitt, Allison

Publication type:

Article

Elan develop external links to maximise lifelong learning potential.

Published in:: Engineers Journal, 2006, v. 60, n. 10, p. 616
Publication type:: Article